|
End-of-day quote
Amman S.E.
14/09/2026
|
5-day change | 1st Jan Change | ||
| 2.000 JOD | +6.95% |
|
+5.26% | +25.00% |
| 07-22 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHILADELPHIA PHARMACEUTICALS COMPANY | Generic Pharmaceuticals | +6.95% | +5.26% | +25.00% | +30.72% | +44.93% | 21.16M |
-
|
-
|
-
|
- Stock Market
- Stocks
- PHIL Stock
- Charts Philadelphia Pharmaceuticals Company
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
